ArticleJournal of controlled release : official journal of the Controlled Release Society2009
Missing pieces in understanding the intracellular trafficking of polycation/DNA complexes.
Article in Journal of controlled release : official journal of the Controlled Release Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 47 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Analyzing Molecular Determinants of Nanodrugs' Cytotoxic Effects.International journal of molecular sciences · 2025Pooled it
- pH-Sensitive Amino Lipid-Driven Pore Formation Enables Endosomal Escape of Lipid Nanoparticles.Nature communications · 2026Article
- Polymers for the treatment of Alzheimer's disease.Frontiers in pharmacology · 2025Review
- Polymeric Nanoparticles for Drug Delivery.Chemical reviews · 2024Review
- Enhancing pDNA Delivery with Hydroquinine Polymers by Modulating Structure and Composition.JACS Au · 2023Article
- Osmotically Rupturing Phagosomes in Macrophages Using PNIPAM Microparticles.ACS applied materials & interfaces · 2023Article
- Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer.Acta pharmaceutica Sinica. B · 2023Article
- Engineering poly- and micelleplexes for nucleic acid delivery - A reflection on their endosomal escape.Journal of controlled release : official journal of the Controlled Release Society · 2023Review
- Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery.Research (Washington, D.C.) · 2023Review
- Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2022Review
- Theranostic potential of self-luminescent branched polyethyleneimine-coated superparamagnetic iron oxide nanoparticles.Beilstein journal of nanotechnology · 2022Article
- Polyethyleneimine-Based Lipopolyplexes as Carriers in Anticancer Gene Therapies.Materials (Basel, Switzerland) · 2021Review
- Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2021Review
- Article
- Nanoparticles for protein delivery in planta.Current opinion in plant biology · 2021Review
- Mitochondria-specific delivery system for targeted regulation of mitochondrial gene expression.STAR protocols · 2021Article
- Design, characterization, and intracellular trafficking of biofunctionalized chitosan nanomicelles.Biointerphases · 2020Article
- Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer.Nature communications · 2020Article
- The transient expression of CHIKV VLP in large stirred tank bioreactors.Cytotechnology · 2019Article
- Non-viral transfection vectors: are hybrid materials the way forward?MedChemComm · 2019Review
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.